Caitlin John’s ResMed RMD Stock Holding History

Caitlin John’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17K	Sell	6 -9	-60%	-$1.86K	﹤0.01%	848
2026 Q1	$3.37K	Sell	15 -16	-52%	-$3.99K	﹤0.01%	664
2025 Q4	$7.47K	Sell	31 -5,664	-99%	-$1.45M	﹤0.01%	581
2025 Q3	$1.56M	Buy	5,695 +79	+1%	+$21.6K	1.08%	24
2025 Q2	$1.45M	Buy	5,616 +2,155	+62%	+$514K	1.32%	22
2025 Q1	$775K	Sell	3,461 -5,366	-61%	-$1.25M	0.76%	32
2024 Q4	$2.02M	Buy	8,827 +252	+3%	+$60.7K	1.33%	18
2024 Q3	$2.02M	Buy	+8,575	New	+$1.92M	1.26%	20

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Caitlin John's RMD Position: Q2 2026 in Review

Caitlin John reduced its ResMed (RMD) stake by 60% in Q2 2026, selling an estimated $1.86K and leaving 6 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Caitlin John first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.02M in Q3 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Caitlin John held 6 shares of ResMed worth $1.17K as of Q2 2026.
Caitlin John sold 9 ResMed shares in Q2 2026, an estimated $1.86K.
ResMed made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #848 holding.
Caitlin John first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
Caitlin John's ResMed position peaked at $2.02M in Q3 2024.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.